Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hepatitis

  Free Subscription


Articles published in Am J Gastroenterol

Retrieve available abstracts of 45 articles:
HTML format



Single Articles


    November 2022
  1. KRAMER JR, Cao Y, Li L, Smith D, et al
    Longitudinal Associations of Risk Factors and Hepatocellular Carcinoma in Patients With Cured Hepatitis C Virus Infection.
    Am J Gastroenterol. 2022;117:1834-1844.
    PubMed     Abstract available


  2. SHOREIBAH M
    Continuing Medical Education Questions: November 2022.
    Am J Gastroenterol. 2022;117:1742.
    PubMed     Abstract available


    October 2022
  3. YUN B, Oh J, Ahn SH, Yoon JH, et al
    Comparable mortality between Asian chronic hepatitis B patients under long-term antiviral therapy vs. matched control: a population-based study.
    Am J Gastroenterol. 2022 Oct 25. pii: 00000434-990000000-00555.
    PubMed     Abstract available


    September 2022
  4. VELOZ MFG, Han K, Oakes K, Robertson D, et al
    Results of a model of delivering hepatitis C care in a homeless metropolitan population in England.
    Am J Gastroenterol. 2022 Sep 30. pii: 00000434-990000000-00534.
    PubMed     Abstract available


  5. SOHN W, Chang Y, Cho YK, Hong YS, et al
    Isolated Hepatitis B core antibody positivity and long-term liver-related mortality in Korea: A cohort study.
    Am J Gastroenterol. 2022 Sep 6. pii: 00000434-990000000-00499.
    PubMed     Abstract available


  6. WU S, Zhou J, Wu X, Sun Y, et al
    Comparative Performance of 14 HCC Prediction Models in CHB: A Dynamic Validation at Serial On-Treatment Timepoints.
    Am J Gastroenterol. 2022;117:1444-1453.
    PubMed     Abstract available


    August 2022
  7. SINGH SP, Jindal A, Sharma MK, Sarin SK, et al
    Much more is needed from Hepatitis B Core-related antigen to predict Risk of Liver cancer.
    Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00453.
    PubMed    


  8. WONG RJ, Kaufman HW, Niles JK, Chen C, et al
    Low Performance of Hepatitis Delta Virus Testing Among Two National Cohorts of Chronic Hepatitis B Patients in the United States.
    Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00461.
    PubMed     Abstract available


  9. LIM N, Kwong AJ, Jafri SM, Jesse MT, et al
    Heterogeneity in Center Practices in Liver Transplantation for Alcohol-associated Liver Disease in the United States.
    Am J Gastroenterol. 2022 Aug 1. pii: 00000434-990000000-00443.
    PubMed     Abstract available


    July 2022
  10. WEINBERG EM, Dukewich M, Jakhete N, Stonesifer E, et al
    Early Liver Transplantation for Severe Alcohol-Associated Hepatitis and a History of Prior Liver Decompensation.
    Am J Gastroenterol. 2022 Jul 11. pii: 00000434-990000000-00432.
    PubMed     Abstract available


  11. GONZALEZ SA, Kamath PS
    Lung Infection in Severe Alcohol-related Hepatitis: Not to be Underestimated.
    Am J Gastroenterol. 2022;117:1044-1045.
    PubMed    


    June 2022
  12. INNES H, Hamill V, McDonald SA, Hayes PC, et al
    Comparing predicted probability of hepatocellular carcinoma in cirrhosis patients to the general population: an opportunity to improve risk communication?
    Am J Gastroenterol. 2022 Jun 24. pii: 00000434-990000000-00428.
    PubMed     Abstract available


  13. GENG CX, Gudur A, Patterson D, Stotts MJ, et al
    Concordance of ICD-10 Codes and the Clinical Diagnosis of Alcoholic Hepatitis.
    Am J Gastroenterol. 2022 Jun 17. pii: 00000434-990000000-00420.
    PubMed     Abstract available


  14. CALVARUSO V, Celsam C, D'Ambrosio R, Simone F, et al
    RESIST-HCV criteria to monitor progression of low-risk esophageal varices in patients with compensated cirrhosis after HCV eradication. The SIMPLE study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices.
    Am J Gastroenterol. 2022 Jun 17. pii: 00000434-990000000-00413.
    PubMed     Abstract available


  15. FONTANA RJ, Engle RE, Hayashi PH, Gu J, et al
    The Incidence of Hepatitis E infection in American Patients with Suspected Drug-Induced Liver Injury is low and declining: The DILIN Prospective Study.
    Am J Gastroenterol. 2022 Jun 10. pii: 00000434-990000000-00401.
    PubMed     Abstract available


    May 2022
  16. AMPUERO J, Carmona I, Sousa F, Rosales JM, et al
    Correction to: A 2-Step Strategy Combining FIB-4 With Transient Elastography and Ultrasound Predicted Liver Cancer After HCV Cure.
    Am J Gastroenterol. 2022;117:819.
    PubMed    


  17. MORALES-ARRAEZ D, Ventura-Cots M, Altamirano J, Abraldes JG, et al
    Correction to: The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study.
    Am J Gastroenterol. 2022;117:818.
    PubMed    


    March 2022
  18. NTANDJA WANDJI LC, Ningarhari M, Lemaitre E, Khaldi M, et al
    Lung infection impacts access to treatment and short-term outcome in patients with severe alcohol-related hepatitis treated with corticosteroids.
    Am J Gastroenterol. 2022 Mar 28. pii: 00000434-990000000-00311.
    PubMed     Abstract available


  19. YUN B, Ahn SH, Yoon JH, Kim BK, et al
    Clinical indication of aspirin associated with reduced risk of liver cancer in chronic hepatitis B: A nationwide cohort study.
    Am J Gastroenterol. 2022 Mar 14. pii: 00000434-990000000-00276.
    PubMed     Abstract available


    February 2022
  20. TSENG TC, Hosaka T, Liu CJ, Suzuki F, et al
    Hepatitis B Core-related Antigen Stratifies the Risk of Liver Cancer in HBeAg-negative Patients with Indeterminate Phase.
    Am J Gastroenterol. 2022 Feb 16. pii: 00000434-990000000-00267.
    PubMed     Abstract available


  21. JENA A, Choudhury A, Singh AK
    MELD vs Maddrey Discriminant Function in Alcoholic Hepatitis: The Battle for the Best Score.
    Am J Gastroenterol. 2022 Feb 10. pii: 00000434-990000000-00248.
    PubMed    


  22. CHANG R, Chen HY, Wei JC
    Increased Cancer Risk in Autoimmune Hepatitis: A Danish Nationwide Cohort Study.
    Am J Gastroenterol. 2022 Feb 8. pii: 00000434-990000000-00243.
    PubMed    


  23. LI J, Henry L, Nguyen MH
    Chronic hepatitis B and fatty liver -weal or woe?
    Am J Gastroenterol. 2022 Feb 2. pii: 00000434-990000000-00238.
    PubMed    


    January 2022
  24. FAYED A, Hegazy MT, Biard L, Vieira M, et al
    Relapse of HCV-Cryoglobulinemic Vasculitis Following Sustained Viral Response after Interferon-free Direct-Acting Antivirals.
    Am J Gastroenterol. 2022 Jan 29. pii: 00000434-990000000-00234.
    PubMed     Abstract available


    December 2021
  25. MORALES-ARRAEZ D, Ventura-Cots M, Altamirano J, Abraldes JG, et al
    The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study.
    Am J Gastroenterol. 2021 Dec 28. pii: 00000434-990000000-00179.
    PubMed     Abstract available


  26. CACOUB P, Asselah T
    Hepatitis B Virus Infection and Extra-Hepatic Manifestations: A Systemic Disease.
    Am J Gastroenterol. 2021 Dec 16. pii: 00000434-990000000-00166.
    PubMed     Abstract available


    October 2021
  27. JENSEN MD, Jepsen P, Vilstrup H, Gronbaek L, et al
    Increased Cancer Risk in Autoimmune Hepatitis: A Danish Nationwide Cohort Study.
    Am J Gastroenterol. 2021 Oct 8. pii: 00000434-990000000-00120.
    PubMed     Abstract available


  28. LI J, Le MH, Barakat MT, Cheung RC, et al
    The Changing Epidemiology of Liver Disease Among US Children and Adolescents From 1999 to 2016.
    Am J Gastroenterol. 2021;116:2068-2078.
    PubMed     Abstract available


    September 2021
  29. LEE HW, Park SY, Lee YR, Lee H, et al
    Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL.
    Am J Gastroenterol. 2021 Sep 10. pii: 00000434-990000000-00096.
    PubMed     Abstract available


  30. AMPUERO J, Carmona I, Sousa F, Rosales JM, et al
    A 2-Step Strategy Combining FIB-4 With Transient Elastography and Ultrasound Predicted Liver Cancer After HCV Cure.
    Am J Gastroenterol. 2021 Sep 9. pii: 00000434-900000000-98663.
    PubMed     Abstract available


  31. CHUANG WL, Hu TH, Buggisch P, Moreno C, et al
    Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal Disease.
    Am J Gastroenterol. 2021;116:1924-1928.
    PubMed     Abstract available


  32. ZAMOR PJ, Brown A, Dylla DE, Dillon JF, et al
    High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence.
    Am J Gastroenterol. 2021;116:1896-1904.
    PubMed     Abstract available


    August 2021
  33. KONSTANTELOS N, Shakeri A, McCormack D, Feld JJ, et al
    Impact of COVID-19 on Prescribing Trends of Direct-Acting Antivirals for the Treatment of Hepatitis C in Ontario, Canada.
    Am J Gastroenterol. 2021;116:1738-1740.
    PubMed     Abstract available


    June 2021
  34. SCHAEFER EAK
    A Deep Ravine Rather Than a Shallow Gap: Many More Bridges Needed to Improve Care of Chronic Hepatitis B in the United States.
    Am J Gastroenterol. 2021 Jun 30. pii: 00000434-990000000-00023.
    PubMed     Abstract available


  35. YU X
    Pay Attention to Distinguish Hepatitis from Novel Coronavirus Hepatitis in the Context of COVID-19 Pandemic.
    Am J Gastroenterol. 2021;116:1354-1355.
    PubMed    


  36. RINALDI L, Messina V, Di Marco V, Iovinella V, et al
    Factors Enhancing Treatment of Hepatitis C Virus-Infected Italian People Who Use Drugs: The CLEO-GRECAS Experience.
    Am J Gastroenterol. 2021;116:1248-1255.
    PubMed     Abstract available


  37. NGUYEN MH, Atsukawa M, Ishikawa T, Yasuda S, et al
    Outcomes of Sequential Therapy With Tenofovir Alafenamide After Long-term Entecavir.
    Am J Gastroenterol. 2021;116:1264-1273.
    PubMed     Abstract available


    April 2021
  38. TRAN S, Jeong D, Henry L, Cheung RC, et al
    Initial Evaluation, Long-Term Monitoring, and Hepatocellular Carcinoma Surveillance of Chronic Hepatitis B in Routine Practice: A Nationwide US Study.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98796.
    PubMed     Abstract available


  39. SHARMA S, Saraya A
    Avoiding Beta Blockers in Patients of Hepatitis C Virus-Related Compensated Cirrhosis With Clinically Significant Portal Hypertension After Cure With Antivirals: Are We There Yet?
    Am J Gastroenterol. 2021 Apr 9. pii: 00000434-900000000-98829.
    PubMed    


  40. JI D, Chen Y, Shang Q, Liu H, et al
    Unreliable Estimation of Fibrosis Regression During Treatment by Liver Stiffness Measurement in Patients With Chronic Hepatitis B.
    Am J Gastroenterol. 2021 Apr 8. pii: 00000434-900000000-98824.
    PubMed     Abstract available


  41. KHALILI M, Kleiner DE, King WC, Sterling RK, et al
    Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B.
    Am J Gastroenterol. 2021 Apr 8. pii: 00000434-900000000-98823.
    PubMed     Abstract available


  42. EISA M, Kennedy R, Teferra R, Heckroth M, et al
    SARS-COV-2 Infection in Patients With Alcohol-Associated Hepatitis: Metabolic Similarities and Treatment Challenges.
    Am J Gastroenterol. 2021;116:847-848.
    PubMed    


    March 2021
  43. ROGAL S, Youk A, Agbalajobi O, Zhang H, et al
    Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis.
    Am J Gastroenterol. 2021 Mar 30. pii: 00000434-900000000-98834.
    PubMed     Abstract available


  44. WONG RJ, Jain MK, Therapondos G, Niu B, et al
    Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems.
    Am J Gastroenterol. 2021 Mar 1. pii: 00000434-900000000-98873.
    PubMed     Abstract available


    February 2021
  45. TAN HK, Teng MLP, Soh AYS, Cheo SHY, et al
    Poor Outcomes of Cirrhosis due to Nonalcoholic Steatohepatitis Compared With Hepatitis B After Decompensation With Ascites.
    Am J Gastroenterol. 2021 Feb 1. doi: 10.14309/ajg.0000000000001176.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: